GLIS2 and leukemia: Furthermore, CD56+CD45−-cells are always suggestive of BM metastases of various solid tumors [17,20,21,44], and even BM differentiation between leukemia and nonhematopoietic tumors is one of the main challenges in CBFA2T3::GLIS2-positive AMKL diagnosis [17,21].